v3.26.1
INCOME TAXES - Narrative (Details)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended 32 Months Ended
Mar. 12, 2025
USD ($)
Jan. 13, 2021
USD ($)
Aug. 15, 2017
USD ($)
Jun. 27, 2026
USD ($)
Jun. 28, 2025
USD ($)
Jun. 27, 2026
USD ($)
Jun. 28, 2025
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2012
USD ($)
Dec. 31, 2011
USD ($)
Dec. 31, 2010
USD ($)
Dec. 31, 2009
USD ($)
Apr. 20, 2017
year
Income Tax Contingency [Line Items]                          
Income tax expense (benefit)       $ (16.9) $ (3.7) $ 1.8 $ (11.9)            
Income tax examination, penalties and interest expense     $ 134.1           $ 24.7 $ 40.1 $ 41.8 $ 27.5  
Cumulative deferred charge related to tax litigation       $ 113.3   $ 113.3              
Royalty conceded on all omeprazole sales as a percent of refund claims (percent)           5.24%              
IRS notice of proposed audit adjustment from 2013, 2014 and 2015   $ 141.6                      
IRS notice of proposed audit adjustment for ANDA from 2013, 2014, and 2015   21.9                      
IRS issued to reduce the deductible interest expense $ 348.2                        
OBBBA                          
Income Tax Contingency [Line Items]                          
Income tax expense (benefit)               $ 21.7          
Minimum                          
Income Tax Contingency [Line Items]                          
Income tax examination, estimate of additional tax expense, excluding interest and penalties   25.0                      
Maximum                          
Income Tax Contingency [Line Items]                          
Income tax examination, estimate of additional tax expense, excluding interest and penalties   $ 128.0                      
Internal Revenue Service (IRS)                          
Income Tax Contingency [Line Items]                          
Income tax examination, number of taxable years | year                         4